Q3 2022 X4 Pharmaceuticals Inc Earnings Call Transcript
Greetings and welcome to X4 Pharmaceuticals third quarter 2022 conference call. At this time, all participants are in a listen only mode. A question answer session will follow the formal presentation. As a reminder, this conference call is being recorded. It is now my pleasure to introduce your host, Dan Perry [ph] from LifeSci Advisors. Please begin.
Thank you, operator. And good morning, everyone. Presenting on today's call will be X4's Chief Executive Officer Dr. Paula Ragan and Chief Medical Officer Diego Cadavid.
We will also hear briefly from the company's new Chief Commercial Officer Mark Baldry and company board member and incoming interim Chief Medical Officer Dr. Murray Stewart. Following prepared remarks, we will open the call to your questions and will be joined by Chief Financial Officer Adam Mostafa, Chief Scientific Officer Art Taveras, and Chief Operating Officer Mary DiBiase.
As a reminder on today's call, the company will be making forward-looking statements
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |